PMID: 16702730

Maekawa K, Itoda M, Sai K, Saito Y, Kaniwa N, Shirao K, Hamaguchi T, Kunitoh H, Yamamoto N, Tamura T, Minami H, Kubota K, Ohtsu A, Yoshida T, Saijo N, Kamatani N, Ozawa S, Sawada J
Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population.
Drug Metab Pharmacokinet. 2006 Apr;21(2):109-21., [PubMed]
Sentences
No. Mutations Sentence Comment
10 ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:10:131
status: VERIFIED
view ABCG2 p.Ser13Leu details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:10:159
status: VERIFIED
view ABCG2 p.Gly354Arg details
In addition to 9 previously reported nonsynonymous single nucleotide polymorphisms (SNPs), 2 novel nonsynonymous SNPs, 38CÀT (Ser13Leu) and 1060GÀA (Gly354Arg), were found with minor allele frequencies of 0.3z. Login to comment
17 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16702730:17:727
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16702730:17:728
status: NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16702730:17:713
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16702730:17:714
status: NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:17:1170
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:17:1171
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:17:1894
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:17:1895
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:17:1960
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:17:1961
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:17:1143
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:17:1144
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:17:1725
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:17:1726
status: NEW
view ABCG2 p.Val12Met details
In vitro studies have also indicated that a number of anticancer drugs are good substrates for ABCG2: e.g. topotecan, an irinotecan metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), and its glucuronide conjugate, SN-38G.8–10) Indeed, inhibition of the murine ABCG2 homologue, Bcrp 1, increases the bioavailability of topotecan when orally administered to mdr1aW1b- deˆcient mice.11) In a clinical study, coadministration of topotecan with GF120918, a dual inhibitor for ABCG2 and P-glycoprotein, was shown to markedly increase the bioavailability and systemic exposure of topotecan.12) The cloning of ABCG2 from drug-selected cell lines revealed that acquired amino acid substitutions at residue 482 (Arg482Gly and Arg482Thr) of ABCG2 resulted in marked alterations in substrate recognition and transport ability.13) Thereafter, naturally occurring genetic variations in ABCG2 have been extensively examined in various ethnic populations14–21) because they were expected to explain interindividual diŠerences in oral bioavailability and clearance of ABCG2 substrate drugs.22) Two nonsynonymous polymorphisms, 34GÀA (Val12Met) and 421CÀA (Gln141Lys), were detected at relatively high frequencies in most ethnic groups including Caucasians, Asians, and Africans.14–16,18–21,23) Both polymorphisms were reported to be associated with reduced protein expression in vitro andWor the increased sensitivity of the expressed cells toward several anticancer drugs although con‰icting data were also reported.16,24–26) The expression of ABCG2 protein in placenta was signiˆcantly lower in homozygotes with the 421A alleles than in those with the 421C alleles, while 34GÀA (Val12Met) did not aŠect ABCG2 protein expression.23) However, in intestinal samples, no association was found between the ABCG2 protein levels and the 421CÀA (Gln141Lys) genotype.18) A pharmacokinetic study showed that 421A (Gln141Lys) was unlikely to in‰uence the in vivo disposition of irinotecan in European Caucasian cancer patients.27) On the other hand, di‰omotecan pharmacokinetics were signiˆcantly aŠected by the 421A genotype.28) To explain these inconsistencies, the elucidation of the haplotype structure of ABCG2 would be helpful; however, only limited information is available for the linkage disequilibrium (LD) proˆle and haplotype structure of this gene.20,21) Also, to facilitate future pharmacogenetic studies on ABCG2 genetic variations, haplotype analysis using its high-density SNPs found in a large number of samples is warranted. Login to comment
70 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:70:108
status: VERIFIED
view ABCG2 p.Val12Met details
The observed allele frequencies were all in Hardy-Weinberg equilibrium (pÀ0.05) except for 34GÀA (Val12Met) and IVS2 {36AÀG (p0.028 for both variations). Login to comment
73 ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:73:42
status: VERIFIED
view ABCG2 p.Ser13Leu details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:73:70
status: VERIFIED
view ABCG2 p.Gly354Arg details
Two novel nonsynonymous SNPs, 38CÀT (Ser13Leu) and 1060GÀA (Gly354Arg), were heterozygous in diŠerent patients at an allele frequency of 0.003. Login to comment
80 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:80:146
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:80:122
status: VERIFIED
view ABCG2 p.Val12Met details
However, marked ethnic diŠerences in the allele frequencies were observed with |1203ä |1200delCTCA, 34GÀA (Val12Met), 421CÀA (Gln141Lys), and some intronic variations. Login to comment
85 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:85:290
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:85:263
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 16702730:85:747
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 16702730:85:773
status: VERIFIED
view ABCG2 p.Phe489Leu details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 16702730:85:721
status: VERIFIED
view ABCG2 p.Phe431Leu details
115Haplotype Structure in Human ABCG2 (from |1836 to |1175 bp upstream of the translational start site) of the basal promoter,30) and was suggested to in‰uence irinotecan pharmacokinetics.31) The frequencies of two well-known nonsynonymous SNPs, 34GÀA (Val12Met) and 421CÀA (Gln141Lys), were 0.192 and 0.319 in our study, which were comparable to those in Chinese (0.204 and 0.222–0.350, respectively).20,27) However, the frequencies were much higher than those in Caucasians (0.02–0.065 and 0.08–0.15), African-Americans (0–0.09 and 0–0.05), and a Swedish population (0.02 and 0.1).18,19,21,23,27) Of other relatively rare nonsynonymous SNPs, 376CÀT (Gln126X), 1291TÀC (Phe431Leu), 1322GÀA (Ser441Asn), 1465TÀC (Phe489Leu), and 1515delC (Phe506SerfsX4) were already detected in a Japanese population by Itoda et al.17) andWor Kobayashi et al.,23) but not found in other ethnic groups. Login to comment
86 ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:86:51
status: VERIFIED
view ABCG2 p.Arg160Gln details
ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:86:128
status: VERIFIED
view ABCG2 p.Arg160Gln details
Recently, the two nonsynonymous SNPs, 479GÀA (Arg160Gln) and 1723CÀT (Arg575X), have been reported by Bosch et al.21) Arg160Gln and Arg575X were found as heterozygotes in single Asian and Caucasian subjects, respectively. Login to comment
87 ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:87:44
status: VERIFIED
view ABCG2 p.Arg160Gln details
Therefore, the distribution of 479GÀA (Arg160Gln) might be restricted in Asians, while 1723CÀT (Arg575X) is likely to be detected both in Caucasians and Japanese at low frequencies. Login to comment
89 ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 16702730:89:290
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 16702730:89:341
status: VERIFIED
view ABCG2 p.Asn590Tyr details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 16702730:89:177
status: VERIFIED
view ABCG2 p.Asp620Asn details
ABCG2 p.Pro269Ser
X
ABCG2 p.Pro269Ser 16702730:89:110
status: VERIFIED
view ABCG2 p.Pro269Ser details
On the other hand, several nonsynonymous SNPs reported in other ethnic groups were not detected: 805CÀT (Pro269Ser) found in Chinese at a 0.037 frequency,20) 1858GÀA (Asp620Asn) in undeˆned (combined) ethnicities14) (0.011) and in a Dutch population21) (0.005), 616AÀC (Ile206Leu) in Hispanics (0.100), and 1768AÀT (Asn590Tyr) in Caucasians (0.010).18) Thus, these SNPs are either ethnic-speciˆc or rare. Login to comment
98 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:98:114
status: VERIFIED
view ABCG2 p.Val12Met details
As previously reported in various ethnic groups,14,18) perfect LD (r2 1.0) was observed between 34GÀA (Val12Met) and IVS2{ 36AÀG. Login to comment
100 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 16702730:100:86
status: VERIFIED
view ABCG2 p.Ser441Asn details
Because the two rare nonsynonymous variations, 1515delC (F506SfsX4) and 1322GÀA (Ser441Asn), were found in the same patient, they were statistically estimated to be linked with each other. Login to comment
101 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:101:129
status: VERIFIED
view ABCG2 p.Gln141Lys details
Strong LDs (r2 À0.7) were observed between |262CÀT and 1098GÀA (Glu366Glu) (r2 0.798), between 421CÀA (Gln141Lys) and IVS12{49GÀT (r2 0.709), and among IVS11{20AÀG, IVS13–21CÀT, and IVS15{110CÀT (r2 À0.720). Login to comment
115 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:115:135
status: VERIFIED
view ABCG2 p.Gln141Lys details
No close associations were observed (r2 º0.70) between the variations across the blocks except for one pair of SNPs, 421CÀA (Gln141Lys) and IVS12{49GÀT, Fig. . Login to comment
130 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:130:130
status: NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:130:131
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:130:159
status: NEW
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:130:160
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:130:244
status: NEW
view ABCG2 p.Arg160Gln details
ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:130:245
status: VERIFIED
view ABCG2 p.Arg160Gln details
ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:130:215
status: NEW
view ABCG2 p.Ser13Leu details
ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:130:216
status: VERIFIED
view ABCG2 p.Ser13Leu details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:130:279
status: NEW
view ABCG2 p.Gly354Arg details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:130:280
status: VERIFIED
view ABCG2 p.Gly354Arg details
In Block 1, seven haplotype groups (*1 to *7) were inferred, and the groups of *2 to *7 harbored non-synonymous SNPs, 421CÀA (Gln141Lys) (*2), 34GÀA (Val12Met) (*3), 376CÀT (Gln126X) (*4), 38CÀT (Ser13Leu) (*5), 479GÀA (Arg160Gln) (*6), and 1060GÀA (Gly354Arg) (*7). Login to comment
134 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:134:222
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:134:153
status: VERIFIED
view ABCG2 p.Val12Met details
The haplotype-tagging SNPs (htSNPs) that were able to resolve the 8 common haplotypes were the following 7 variations: IVS1–99GÀA, 34GÀA (Val12Met), IVS2–93TÀC, 376CÀT (Gln126X), 421CÀA (Gln141Lys), IVS6–217AÀG, and IVS6–204CÀT. Login to comment
141 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 16702730:141:290
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 16702730:141:228
status: VERIFIED
view ABCG2 p.Phe489Leu details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 16702730:141:259
status: VERIFIED
view ABCG2 p.Phe431Leu details
The thick lines represent the combinations with frequencies over 10z, and the thin lines represent the combinations with frequencies of 1.0 to 9.9z. 118 Keiko MAEKAWA et al. haplotype harboring nonsynonymous SNPs, 1465TÀC (Phe489Leu) (*2), 1291TÀC (Phe431Leu) (*3), 1322GÀA (Ser441Asn)W1515delC (Phe506SerfsX) (*4), and 1723CÀT (Arg575X) (*5), respectively. Login to comment
152 ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:152:59
status: VERIFIED
view ABCG2 p.Ser13Leu details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:152:72
status: VERIFIED
view ABCG2 p.Gly354Arg details
Eleven nonsynonymous variations, including two novel ones (Ser13Leu and Gly354Arg), were found. Login to comment
154 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:154:461
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:154:40
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:154:273
status: VERIFIED
view ABCG2 p.Val12Met details
Mizuarai et al. showed that 34GÀA (Val12Met) was associated with reduced drug resistance in polarized LLC-PK1 cells, which might be caused by its impaired apical membrane localization.25) In contrast, several groups did not ˆnd any signiˆcant eŠects of Val12Met on the protein expression levels as well as drug resistance using stable and transient mammalian expression systems.16,24,26) According to Imai et al. and Kondo et al.,16,24) the Gln141Lys substitution resulted in decreased protein expression and reduced drug resistance. Login to comment
155 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 16702730:155:219
status: VERIFIED
view ABCG2 p.Ser441Asn details
These results are inconsistent with those obtained by Mizuarai et al. and Morisaki et al., in which the reduced drug resistance was not caused by the decreased protein expression.25,26) Kondo et al. have shown that the Ser441Asn variant was not localized to apical membranes, but remains intracellular in the transfected LLC-PK1 cells,24) suggesting its reduced activity. Login to comment
158 ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 16702730:158:116
status: VERIFIED
view ABCG2 p.Phe489Leu details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 16702730:158:101
status: VERIFIED
view ABCG2 p.Phe431Leu details
ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:158:79
status: VERIFIED
view ABCG2 p.Arg160Gln details
ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:158:69
status: VERIFIED
view ABCG2 p.Ser13Leu details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:158:90
status: VERIFIED
view ABCG2 p.Gly354Arg details
The functional eŠects of the other ˆve nonsynonymous SNPs (Ser13Leu, Arg160Gln, Gly354Arg, Phe431Leu, and Phe489Leu) have not yet been characterized. Login to comment
159 ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:159:178
status: VERIFIED
view ABCG2 p.Arg160Gln details
ABCG2 p.Ser13Leu
X
ABCG2 p.Ser13Leu 16702730:159:168
status: VERIFIED
view ABCG2 p.Ser13Leu details
ABCG2 p.Gly354Arg
X
ABCG2 p.Gly354Arg 16702730:159:193
status: VERIFIED
view ABCG2 p.Gly354Arg details
Using the PolyPhen program (http:WW www.bork.embl-heidelberg.deWPolyPhenW) to predict the functional eŠect of these amino acid substitutions, three substitutions, Ser13Leu, Arg160Gln, and Gly354Arg, were estimated to cause possible alterations in protein function based on the PSIC (position speciˆc independent count) proˆle score. Login to comment
160 ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 16702730:160:9
status: VERIFIED
view ABCG2 p.Arg160Gln details
Notably, Arg160Gln is located in the functionally important ATP-binding region between the Waker A (amino acids 80–89) and Walker B (amino acids 206–210) motifs. Login to comment
162 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:162:34
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:162:11
status: VERIFIED
view ABCG2 p.Val12Met details
Except for Val12Met, Gln126X, and Gln141Lys, the allele frequencies of eight nonsynonymous SNPs were less than 0.01, and these low frequency variations do not largely contribute to the overall heterozygosity of ABCG2; however, they might have clinical importance. Login to comment
174 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:174:91
status: VERIFIED
view ABCG2 p.Gln141Lys details
Nevertheless, the frequency (31.9z) of the haplotype *2a in Block 1 harboring 421CÀA (Gln141Lys) was comparable to their counterpart (20.4z). Login to comment
176 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 16702730:176:38
status: VERIFIED
view ABCG2 p.Gln141Lys details
Therefore, the substitution itself of Gln141 to Lys is likely to be responsible for the reduced expression of ABCG2 protein in placenta as demonstrated by Kobayashi et al.23) Furthermore, Chinese and Japanese share several common Block 2 haplotypes, *1a, *1b, *1c, and *1dW *1e. Login to comment
188 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:188:93
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:188:254
status: VERIFIED
view ABCG2 p.Val12Met details
In a Swedish population, |1203ä |1200delCTCA was reported to be linked with 34GÀA (Val12Met), the representative SNP in the Block1 *3 group.19) Due to the high (0.54) and low (0.02) allele frequencies of |1203ä|1200delCTCA and 34GÀA (Val12Met), respectively, the Block |1 *1b–Block 1 *3 combination is not predominant in the Swedish population. Login to comment
189 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 16702730:189:183
status: VERIFIED
view ABCG2 p.Val12Met details
Zhou et al. suggested that |1203ä |1200delCTCA might in‰uence pharmacokinetic parameters of irinotecan.31) On the other hand, the functional signiˆcance of 34GÀA (Val12Met) is not fully elucidated as described above.16,24–26) In this context, the major combination in Japanese, Block |1 *1b–Block 1 *3a, should be carefully considered in pharmacogenetic studies in Japanese. Login to comment